. 2014 Spring;2(1):30–41.

Table 1.

Patient and disease characteristics

	Variable	Value	Patients %
Age (y)	Median	48	Not applicable
Age (y)	Range	36 to 67	Not applicable
Sex (no. of patients)	Male	14	63.6
Sex (no. of patients)	Female	8	36.4
Chromogranin A (ng/mL)	Median	468	Not applicable
Chromogranin A (ng/mL)	Range	118-5400	Not applicable
Diagnosis	Carcinoid	11	50
	Pancreatic NET	6	27.3
	Gastrinoma	1	4.55
	Neuroendocrine tumor NOS	4	18.1
Treatment	Surgery	2	9.1
	Octreotide	6	27.3
	Surgery and octreotide	4	18.1
	Surgery and chemotherapy, radiotherapy, or both	2	9.1
	Octreotide and chemotherapy	3	13.6
	None	5	22.7
Indication for scintigraphy	Staging	8	36.3
Indication for scintigraphy	Restaging	14	63.7